Toulouse Cedex 9

• Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer Pending
  2025-520946-31-00 1 Non-Small Cell Lung Cancer
• A multicenter phase 2 study of Belantamab mafodotin and Mezigdomide in combination with a phase Ib Safety run in patients with relapsed mult … Pending
  2025-520976-25-00 4 Relapsed/refractory multiple myeloma
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• CHILURSO: Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy Pending
  2025-521317-50-00 5 Cholestatic hepatitis induced by immune checkpoint inhibitors (ICIs)
• FILO-AML-01-MIVONU A single arm phase II study investigating the efficacy and safety of the addition of ivosidenib to oral azacitidine (Onur … Pending
  2025-521322-14-00 4 Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation,
• MAINRITSys : Rituximab vs placebo for maintenance in systemic sclerosis – interstitial lung disease Pending
  2025-521331-36-00 10 Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
• A Phase 1 Study of AUTX-703 in Participants with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes Pending
  2025-521394-13-00 1 Relapsed/refractory Acute Myeloid Leukemia or relapsed/refractory myel
• Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma w … Pending
  2025-521437-88-00 4 head and neck squamous cell carcinoma
• ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending
  2025-521478-32-00 5 PEDIATRIC ACUTE MYOCARDITIS
• PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot … Pending
  2025-521571-30-00 5 Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
• Clinical trial evaluating the biological activity of a new drug identified as prifetrastat (PF-07248144), combined with fulvestrant for the … Pending
  2025-521982-29-00 4 Adult patients with advanced hormone receptor positive (HR+), HER2- br
• PREP-ANCA - Comparison of a strategy based on clinic-biological surveillance versus pre-emptive treatment with rituximab in the event of ANC … Pending
  2025-522049-23-00 6 granulomatosis with polyangiitis and microscopic polyangiitis
• REVITALISE Study Pending
  2025-522060-32-00 4 STEMI (ST elevated Myocardial Infarction)
• Study of Nemolizumab for the treatment of adults with systemic sclerosis Pending
  2025-522294-11-00 4 Systemic sclerosis
• ILHEP : Effect of perioperative Intravenous Lidocaine on postoperative opioid related-side effects after open HEPatectomy: a multicentre pro … Pending
  2025-522462-73-00 6 Postanesthetic complications in patients undergoing open hepatectomy
• A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L … Pending
  2025-522818-23-00 5 Small Cell Lung Cancer (SCLC)
• A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending
  2025-522855-25-00 5 Urinary Bladder Neoplasms
• Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis Pending
  2025-522904-26-00 3 Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephri
• A study to investigate the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of a CD19/CD20 T-cell engager in participants with … Pending
  2025-522932-15-00 3 Systemic Lupus Erythematosus
• Effects of butyrate enemas on postoperative intestinal motility disorders in Hirschsprung’s disease Pending
  2025-523094-42-00 5 Hirschsprung's disease
• Women victims of violences : PTSD treatment by traumatic memory reactivation under the influence of propranolol (VIOFEM) Pending
  2025-523107-30-01 5 Post-traumatic stress disorder (PTSD)
• A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma. Pending
  2025-523285-25-00 5 Relapsed or Refractory Multiple Myeloma
• Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc) Pending
  2025-523288-39-00 4 Diffuse Cutaneous Systemic Sclerosis (dcSSc)
• Study with IDE849 for patients with DLL3 positive cancer, including small cell lung cancer Pending
  2025-523438-24-00 9 DLL3 Expressing Tumors Including Small Cell Lung Cancer

Showing 49–72 of 906 trials